DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Mountzios G, Dimopoulos MA, Bamias A et al.
Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Acta Oncol 2007;
46: 221-229
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.